Abiomed Reports Record Revenue of $29.5 Million and Profitability for Second Quarter of Fiscal 2012, Driven by 40% Impella Growth

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011.

Back to news